CNBX PHARMACEUTICALS INC. (CNBX) Return on equity 2018–2022
CNBX PHARMACEUTICALS INC. (CNBX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-228.1%FY2022 · since FY2018: -142.8% → -228.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -228.1% | -51.2 pp |
| FY2021 | -176.9% | +246.3 pp |
| FY2020 | -423.2% | -430.9 pp |
| FY2019 | 7.7% | +150.4 pp |
| FY2018 | -142.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More CNBX financial trends
CNBX RevenueCNBX Net incomeCNBX Net marginCNBX Gross profitCNBX Gross marginCNBX Operating incomeCNBX Operating marginCNBX Operating cash flowCNBX Free cash flowCNBX Capital expendituresCNBX Stock buybacksCNBX Dividends paidCNBX Total assetsCNBX Total liabilitiesCNBX Shareholders’ equityCNBX overview →